Lung Neoplasms: all 7,334 studies
Page 12 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90)RecruitingNCT05872867Phase 1
- Detection of Abnormal Respiratory Cell Populations in Lung Cancer Screening Patients Using the CyPath Lung AssayNot yet recruitingNCT05870592
- Phase II Study of SY-3505 in Patients With ALK-positive NSCLC Who Have Failed Prior Second-Generation ALK TKIRecruitingNCT05869162Phase 2
- A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT05863325Phase 2
- Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung CancerEnrolling by invitationNCT05863013Not applicable
- A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)Not yet recruitingNCT05859217Phase 2
- Precision Lung Cancer Survivorship Care InterventionRecruitingNCT05857995Not applicable
- Exploring the Neo-Adjuvant Therapy Effects on Lung Cancer Through Monitoring and Assessment of Tumor EnvironmentRecruitingNCT05857800
- Cough Capture as a Portal Into the LungRecruitingNCT05854563
- Italian Lung Cancer Observational StudyEnrolling by invitationNCT05851755
- Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized LidocaineNot yet recruitingNCT05850702Phase 4
- Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors)Not yet recruitingNCT05842018Phase 2
- Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerRecruitingNCT05841472Phase 2
- Multimodalitic Imaging in the N-stage of Lung CancerNot yet recruitingNCT05840094Not applicable
- Low Volume High Intensity Interval Training in Operated Lung Cancer PatientsRecruitingNCT05837429Not applicable
- Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint InhibitorsRecruitingNCT05834413Not applicable
- Healthy Homes StudyRecruitingNCT05833334Not applicable
- A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid TumorsRecruitingNCT05830097Phase 1/2
- Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World SettingRecruitingNCT05826756
- Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain MetastasesNot yet recruitingNCT05812534Phase 2
- Dietary Intervention for NSCLC Patients Treated With ICIRecruitingNCT05805319Not applicable
- Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung LesionsRecruitingNCT05804786
- Lung Cancer Multi-omics Digital Human Avatars for Integrating Precision Medicine Into Clinical PracticeNot yet recruitingNCT05802771
- Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung CancerNot yet recruitingNCT05802654Not applicable
- Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI StudyRecruitingNCT05802186Not applicable
- Dose Attenuated Chemotherapy in Compromised Patients With Lung CancerRecruitingNCT05800587Phase 2
- Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung CancerRecruitingNCT05800223Phase 3
- Panomic Approach to Immune-Connected Assays in Small Cell Lung CancerRecruitingNCT05797493
- Lung Tumor Protein Synthesis Rates in Lung Cancer PatientsRecruitingNCT05794529
- Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for CancerRecruitingNCT05787834Not applicable
- Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesRecruitingNCT05786924Phase 1/2
- DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating MutationsRecruitingNCT05786716Phase 2/3
- Cadonilimab Monotherapy as Neoadjuvant Therapy for Resectable II-IIIA Squamous Cell Lung CancerNot yet recruitingNCT05784974Phase 2
- Health Opportunities and Promoters of Equitable Screening for Lung CancerRecruitingNCT05784922
- Advanced Data-Aided Medicine Part Lung CancerRecruitingNCT05783024
- IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid TumorsRecruitingNCT05780307Phase 1
- Examination of Trends in Non-Small Cell Lung Cancer Patients' Medical Study ExperiencesNot yet recruitingNCT05778045
- PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID TrialRecruitingNCT05775939Not applicable
- Examining Clinical Trial Participation for Small Cell Lung Cancer PatientsNot yet recruitingNCT05769504
- YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion MutationsNot yet recruitingNCT05767892Phase 3
- Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung CancerRecruitingNCT05766800Phase 2
- Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung CancerRecruitingNCT05765877Phase 2
- Screening for Lung Cancer in Subjects With Family History of Lung CancerRecruitingNCT05762731
- Determining Clinical Trial Experiences of Lung Cancer PatientsNot yet recruitingNCT05760170
- Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLCRecruitingNCT05754203Not applicable
- Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid TumoursRecruitingNCT05752552Phase 1
- Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung CancerRecruitingNCT05746325Not applicable
- Effect of Sleep Disorder on the Development of Lung TumorsNot yet recruitingNCT05745506
- First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLCRecruitingNCT05745350Phase 2
- Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial IntelligenceRecruitingNCT05739331
- The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung CancerRecruitingNCT05735028Phase 1
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid TumorsRecruitingNCT05733000Phase 2
- A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of RelapseRecruitingNCT05732974
- SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)RecruitingNCT05731518Phase 1/2
- TEAS for the Treatment of Pain in Bone Metastases of Lung CancerNot yet recruitingNCT05730972Not applicable
- SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)RecruitingNCT05724264Not applicable
- Impact of Lazertinib Dose Modification on Effectiveness and SafetyNot yet recruitingNCT05716672
- BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung CancerNot yet recruitingNCT05715398Phase 1/2
- Integrating Artificial Intelligence Into Lung Cancer Screening.RecruitingNCT05704920Not applicable
- A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South KoreaRecruitingNCT05703516
- MRI and Biomarkers for Lung Nodules Detected During Lung Cancer ScreeningRecruitingNCT05699213
- Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot StudyRecruitingNCT05693363Not applicable
- SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)RecruitingNCT05689619Not applicable
- Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLCRecruitingNCT05681780Phase 1
- Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of SmokingRecruitingNCT05679349Not applicable
- HSI for Intersegmental Plane Identification During Sublobar Pulmonary ResectionsNot yet recruitingNCT05676788Not applicable
- A Study of TY-1091 in Patients With Advanced Solid TumorsRecruitingNCT05675605Phase 1/2
- Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruitingNCT05673590Phase 3
- DREAM: Double Lung Transplant REgistry Aimed for Lung-limited MalignanciesRecruitingNCT05671887
- Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung CancerRecruitingNCT05669586Phase 2
- Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental ResearchRecruitingNCT05669105
- Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLCNot yet recruitingNCT05668767Phase 2
- Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields （EFE-P100）Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1（PD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody TreatmentNot yet recruitingNCT05661240Phase 2/3
- Evaluation of Vascular Toxicity of Immune Checkpoint Inhibitors in Patients Head and Neck or Lung CancerRecruitingNCT05655663Not applicable
- A Multilevel Approach to Connecting Underrepresented Populations to Clinical TrialsRecruitingNCT05655494
- A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung CancerRecruitingNCT05654454Phase 3
- A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)RecruitingNCT05652686Phase 1/2
- PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC PatientsRecruitingNCT05651802Not applicable
- Effect of an Oral Nutritional Supplement on Muscle Mass During Anticancer TreatmentRecruitingNCT05648955Early Phase 1
- First-Line Treatment for Advanced Non-squamous Non-Small-Cell Lung Cancer With Negative Driver Gene: a Single-center, Single-Arm TrialRecruitingNCT05648071Phase 3
- Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung CancerNot yet recruitingNCT05647330Phase 2
- LIVInG With chrONic Cancer TrEatments (LONGEVITI) StudyRecruitingNCT05645510
- Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)RecruitingNCT05642572Phase 2
- Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to ImmunotherapyRecruitingNCT05636605
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Lung CancerRecruitingNCT05632913Not applicable
- REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)RecruitingNCT05632809Phase 2
- First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor MalignanciesRecruitingNCT05627960Phase 1
- Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung CancerRecruitingNCT05624996Phase 3
- Proteomics in Small Cell Lung CancerRecruitingNCT05623956
- Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRTRecruitingNCT05623267Phase 2/3
- Web-based Symptom Monitoring and Survival in Advanced Stage Lung CancerNot yet recruitingNCT05621902Not applicable
- Autologous CAR T-Cells Targeting the GD2 Antigen for Lung CancerRecruitingNCT05620342Early Phase 1
- UNC Pleural Fluid RegistryRecruitingNCT05620329
- Carbon Ion Therapy for Peripheral Non-small Cell Lung CancerRecruitingNCT05613452Phase 2
- PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC).RecruitingNCT05602259Not applicable
- Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor MicroenvironmentEnrolling by invitationNCT05600933
- Registry of the Spanish Society of Thoracic SurgeryRecruitingNCT05600569
- Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung CancerNot yet recruitingNCT05595889Phase 2
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsRecruitingNCT05592626Phase 1/2
- Investigating Hereditary Risk In Thoracic Cancers (INHERIT)RecruitingNCT05587439